Recruitment Notice An open, multicenter Phase I dose-escalation study sponsored by Hangzhou Adcoris Biopharma Co., Ltd. to evaluate the safety, pharmacokinetics, immunogenicity, and initial antitumor activity of ZV0203 in patients with advanced solid...